Sunovion Announces Results from Global Phase 2 Bipolar Depression Study
editor The following is a press release *** MARLBOROUGH – Sunovion Pharmaceuticals Inc., today, July 6, announced results from its depressive, bipolar study. The topline results from study SEP380-201, a global,…